Japanese authorities on Thursday approved remdesivir for treatment of COVID-19, the new disease caused by the CCP (Chinese Communist Party) virus.
Japan’s Ministry of Health, Labour, and Welfare granted regulatory approval to Veklury, or remdesivir.
Vials of investigational COVID-19 treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, Calif., on March 18, 2020. Gilead Sciences via Reuters
Zachary Stieber
Senior Reporter
|Updated:
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
